Physician profile
Domenick J Reina
NPI 1295749398
$469,459.97
in general payments reported to CMS, 2019-2025
25 companies · $170K in 2025
The $170K reported for 2025 was more than what 99% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $241 · 2020: $114 · 2021: $246 · 2022: $13K · 2023: $121K · 2024: $165K · 2025: $170K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $397K · Travel and Lodging: $44K · Food and Beverage: $15K · Education: $109.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $397,250.00 |
| Travel and Lodging | $43,784.38 |
| Food and Beverage | $15,084.07 |
| Education | $108.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $466,741.82 | 2019-2025 | Breztri, Tezspire, Airsupra |
| Glaxosmithkline, LLC. | $894.49 | 2020-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Insmed, INC. | $377.60 | 2020-2025 | Arikayce |
| Boehringer Ingelheim Pharmaceuticals, INC. | $369.82 | 2019-2025 | Ofev, Spiriva Respimat, Stiolto Respimat |
| Actelion Pharmaceuticals US, INC. | $178.15 | 2019-2025 | Opsumit, Uptravi |
| Amgen INC. | $159.88 | 2023-2025 | Tezspire |
| Genzyme Corporation | $144.52 | 2021-2024 | |
| Inspire Medical Systems, INC. | $83.21 | 2023-2025 | Inspire |
| Grifols USA, LLC | $71.14 | 2022-2024 | Prolastin-C Liquid |
| Itamar Medical INC | $58.56 | 2024 | Watchpatone |
| Olympus America INC. | $40.68 | 2021 | |
| Mylan Specialty L.P. | $35.46 | 2019-2024 | Yupelri |
| Inogen, INC. | $35.45 | 2023-2024 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Philips North America LLC | $31.85 | 2024 | (Ae4) Secretion Management |
| Bayer Healthcare Pharmaceuticals INC. | $31.02 | 2024 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Axsome Therapeutics, INC. | $30.79 | 2025 | Sunosi |
| Merck Sharp & Dohme LLC | $25.22 | 2024 | Keytruda |
| Regeneron Healthcare Solutions, INC. | $24.66 | 2023 | Dupixent |
| Electromed, INC. | $19.76 | 2024 | Smartvest |
| Vapotherm INC | $19.74 | 2022 | |
| Abbvie INC. | $19.54 | 2025 | |
| Pfizer INC. | $17.93 | 2022 | |
| Shionogi INC | $17.61 | 2021 | |
| Baxter Healthcare | $15.94 | 2024 | Hillrom - Vest System Model 105 Home Care |
| Paratek Pharmaceuticals, INC. | $15.13 | 2025 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Domenick Reina listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.